Search Beyond News…

ABMS criticizes Florida's decision to recognize NBPAS as a certifying entity, warning it undermines physician credentialing standards and public trust in medical advertising

Executive summary: On August 12, 2026, the Florida Board of Medicine approved the National Board of Physicians and Surgeons (NBPAS) as a 'recognizing agency' under its administrative rule governing truth in medical advertising, allowing physicians certified by NBPAS to advertise as board-certified in Florida. This decision challenges the dominance of ABMS as the primary standard for physician board certification in the U.S., potentially legitimizing alternative certification pathways that ABMS views as less rigorous, with implications for physician credentialing, medical advertising integrity, and patient safety.

Who is involved: American Board of Medical Specialties (ABMS), Florida Board of Medicine, National Board of Physicians and Surgeons (NBPAS), physicians seeking certification, and healthcare consumers.

Likely next: ABMS may issue formal guidance to its member boards or pursue advocacy efforts to encourage other states to reject similar recognition; legal or regulatory challenges to Florida's rule are possible if patient advocacy groups or medical societies raise concerns about misleading advertising.

The American Board of Medical Specialties (ABMS) expressed disappointment over the Florida Board of Medicine's approval of the National Board of Physicians and Surgeons (NBPAS) as a 'recognizing agency' under its truth-in-advertising rule. ABMS argues that NBPAS lacks the rigorous, ongoing maintenance of certification required by ABMS-member boards, potentially allowing physicians to claim board certification without meeting nationally recognized standards. This move could erode public confidence in physician credentials and create confusion in medical advertising, particularly as patients increasingly rely on such claims to assess provider qualifications. The decision highlights a growing tension between state-level regulatory flexibility and national efforts to standardize physician quality measurement.

Timeline

Analysis — what this means

Likely next events

Sectors affected

Regulatory implications

Historical parallels

Sources

Related cases

Browse the full archive →